280 related articles for article (PubMed ID: 33001283)
1. Extended curettage versus en bloc resection for the treatment of grade 3 giant cell tumour of the knee with pathologic fracture: a retrospective study.
Jamshidi K; Zandrahimi F; Haji Agha Bozorgi M; Arefpour AM; Bagherifard A; Al-Baseesee HH; Mirzaei A
Int Orthop; 2021 Jan; 45(1):289-297. PubMed ID: 33001283
[TBL] [Abstract][Full Text] [Related]
2. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for local recurrence in extremity-located giant cell tumours of bone with pathological fracture.
Medellin MR; Fujiwara T; Tillman RM; Jeys LM; Gregory J; Stevenson JD; Parry M; Abudu A
Bone Joint J; 2018 Dec; 100-B(12):1626-1632. PubMed ID: 30499317
[TBL] [Abstract][Full Text] [Related]
4. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
Li X; Guo W; Yang Y; Wei R; DU ZY
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
[TBL] [Abstract][Full Text] [Related]
5. [Surgical treatment of giant cell tumors with pathological fracture around the knee].
Liu WF; Yang FJ; Li Y; Li B; Hao L; Niu XH
Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):677-686. PubMed ID: 30157574
[No Abstract] [Full Text] [Related]
6. Does Osteoarticular Allograft Reconstruction Achieve Long-term Survivorship after En Bloc Resection of Grade 3 Giant Cell Tumor of Bone?
Albergo JI; Farfalli GL; Cabas-Geat A; Roitman P; Ayerza MA; Aponte-Tinao LA
Clin Orthop Relat Res; 2020 Nov; 478(11):2562-2570. PubMed ID: 32469488
[TBL] [Abstract][Full Text] [Related]
7. Management of giant cell tumors of the distal radius: a systematic review and meta-analysis.
Koucheki R; Gazendam A; Perera J; Griffin A; Ferguson P; Wunder J; Tsoi K
Eur J Orthop Surg Traumatol; 2023 May; 33(4):759-772. PubMed ID: 35377078
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Reoperation for Local Recurrence Following En Bloc Resection for Bone Giant Cell Tumor of the Extremity.
Tsukamoto S; Mavrogenis AF; Hindiskere S; Honoki K; Kido A; Fujii H; Masunaga T; Tanaka Y; Chinder PS; Donati DM; Errani C
Curr Oncol; 2022 Sep; 29(9):6383-6399. PubMed ID: 36135072
[TBL] [Abstract][Full Text] [Related]
9. Is Navigation-guided En Bloc Resection Advantageous Compared With Intralesional Curettage for Locally Aggressive Bone Tumors?
Farfalli GL; Albergo JI; Piuzzi NS; Ayerza MA; Muscolo DL; Ritacco LE; Aponte-Tinao LA
Clin Orthop Relat Res; 2018 Mar; 476(3):511-517. PubMed ID: 29529633
[TBL] [Abstract][Full Text] [Related]
10. Giant cell tumor with pathologic fracture: should we curette or resect?
van der Heijden L; Dijkstra PD; Campanacci DA; Gibbons CL; van de Sande MA
Clin Orthop Relat Res; 2013 Mar; 471(3):820-9. PubMed ID: 22926445
[TBL] [Abstract][Full Text] [Related]
11. Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation.
Tsukamoto S; Mavrogenis AF; Tanzi P; Leone G; Righi A; Akahane M; Kido A; Honoki K; Tanaka Y; Donati DM; Errani C
J Surg Oncol; 2019 Jun; 119(7):864-872. PubMed ID: 30734307
[TBL] [Abstract][Full Text] [Related]
12. Outcome of re-operation for local recurrence following pre-operative denosumab administration and curettage for giant cell tumour of bone with difficult joint preservation.
Tsukamoto S; Hindiskere S; Honoki K; Mavrogenis AF; Tanaka Y; Chinder PS; Donati DM; Errani C
Int Orthop; 2023 Jan; 47(1):265-273. PubMed ID: 36282294
[TBL] [Abstract][Full Text] [Related]
13. Giant cell tumour of bone.
Aoude A; Nikomarov D; Perera JR; Ibe IK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS
Bone Joint J; 2023 May; 105-B(5):559-567. PubMed ID: 37121582
[TBL] [Abstract][Full Text] [Related]
14. Giant cell tumors of the distal ulna: long-term recurrence rate and functional outcomes of en bloc resection versus curettage in a multicenter study.
Zhou L; Tang J; Shen L; Zhang Z; Yuan T
J Orthop Surg Res; 2023 Sep; 18(1):743. PubMed ID: 37777754
[TBL] [Abstract][Full Text] [Related]
15. The outcome of surgical treatment for recurrent giant cell tumor in the appendicular skeleton.
Wan R; Zhang W; Xu J; Hao P; Yang Y; Shen Y; Ding X; Qiu S
J Orthop Sci; 2012 Jul; 17(4):464-9. PubMed ID: 22526715
[TBL] [Abstract][Full Text] [Related]
16. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
[TBL] [Abstract][Full Text] [Related]
17. Incidence and progression of osteoarthritis following curettage and cementation of giant cell tumor of bone around the knee: long-term follow-up.
Ebeid WA; Badr IT; Mesregah MK; Hasan BZ
J Orthop Traumatol; 2023 Apr; 24(1):11. PubMed ID: 37024720
[TBL] [Abstract][Full Text] [Related]
18. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of Giant Cell Tumor of Bone in the Distal Radius and Ulna].
Mahdal M; Jindra J; Staniczková Zambo I; Pazourek L; Nachtnebl L; Tomáš T
Acta Chir Orthop Traumatol Cech; 2022; 89(3):188-192. PubMed ID: 35815484
[TBL] [Abstract][Full Text] [Related]
20. Novel Strategy of Curettage and Adjuvant Microwave Therapy for the Treatment of Giant Cell Tumor of Bone in Extremities: A Preliminary Study.
Ke J; Cheng S; Yao MY; Chu X; Wang M; Zeng XL; Yang T; Zhang C; Zhong H; Zhang Y
Orthop Surg; 2021 Feb; 13(1):185-195. PubMed ID: 33442922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
